The fact that U.S. markets were preparing to enter the long Labor Day weekend didn't stop two more biotechs from stepping out with initial public offerings (IPOs). Rhythm Pharmaceuticals Inc., which filed its S-1 as Rhythm Holding Co. LLC prior to its expected conversion from a Delaware limited liability to a Delaware corporation and an official name change, is seeking to raise $86.25 million.